Conferences

News & Press

Omicia has been selected as a finalist for the Innovation Showcase at VentureBeat’s HealthBeat 2014 event.  As one of 10 finalists selected from dozens of startups in the digital health space, Omicia will have the opportunity to demonstrate how Opal Clinical will improve patient outcomes by increasing the accuracy, speed, and diagnostic yield of NGS …

Read More

Disorder-causing mutations are hard to detect — they have to be identified among a host of other, innocuous genetic changes. Omicia’s software tools are profiled as Nature takes a look the tools physicians and researchers use to sift through sequenced genomes in search of such mutations.

Read More

Researchers at The University of Texas MD Anderson Cancer Center and other institutions have applied a newly developed software tool, pVAAST, to identify genetic mutations that contribute to a person���s increased risk for developing common, complex diseases, such as cancer. The research is published in the May 2014 edition of the journal Nature Biotechnology.

Read More